Schedule 13D ownership disclosure

LAKESHORE BIOPHARMA CO LTD

Security class unavailable · CUSIP: G9845F109

Event date: 2024-02-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
98,360,094
Percent of class
52.2300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-013772
Form type
SC 13D
Filer
Wong Fung Ching
CIK
CIK 2011156
Filed
Feb 14, 2024
Reporting period
Feb 07, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub